Topaz Pharmaceuticals' Ivermectin Cream In Vitro Data Demonstrates Activity Against Head Lice Eggs
7/11/2011 10:12:11 AM
More...
|
Topaz Pharmaceuticals Announces New Drug Application for the Treatment of Head Lice Accepted by FDA
6/7/2011 10:57:19 AM
More...
|
Topaz Pharmaceuticals Names Dr. Mark Strobeck Chief Business Officer
1/10/2011 6:45:17 AM
More...
|
Topaz Pharmaceuticals Announces Completion of Pivotal Phase 3 Trials of Ivermectin Topical Cream
12/7/2010 10:54:32 AM
More...
|
Topaz Pharmaceuticals Names Bob Radie Chief Executive Officer
11/17/2010 6:37:27 AM
More...
|
Topaz Pharmaceuticals Announces Positive Data from Topical Ivermectin Trials Presented at Society of Pediatric Dermatology
7/28/2010 11:26:41 AM
More...
|
Topaz Pharmaceuticals Receives $20 million Series A Financing
12/3/2007 12:37:51 PM
More...
|
FDA Approves Phase I Clinical Trial of Topaz Pharmaceuticals' New Head Lice Treatment
7/12/2007 8:52:42 AM
More...
|